Compare PK & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PK | OMCL |
|---|---|---|
| Founded | 1946 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Computer Manufacturing |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2014 | 2000 |
| Metric | PK | OMCL |
|---|---|---|
| Price | $11.04 | $43.19 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $11.22 | ★ $55.83 |
| AVG Volume (30 Days) | ★ 4.2M | 577.5K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 8.82% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.05 | ★ 0.25 |
| Revenue | ★ $2,791,000,000.00 | $787,309,000.00 |
| Revenue This Year | $2.40 | $6.77 |
| Revenue Next Year | $2.76 | $5.22 |
| P/E Ratio | $226.30 | ★ $175.52 |
| Revenue Growth | 2.35 | ★ 9.93 |
| 52 Week Low | $9.84 | $26.85 |
| 52 Week High | $12.39 | $51.84 |
| Indicator | PK | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 62.12 |
| Support Level | $10.85 | $30.52 |
| Resistance Level | $11.79 | $46.49 |
| Average True Range (ATR) | 0.34 | 2.10 |
| MACD | -0.03 | 0.33 |
| Stochastic Oscillator | 12.70 | 67.95 |
Park Hotels & Resorts owns upper-upscale and luxury hotels, with 21,042 rooms across 33 hotels in the United States. Park also has interests through joint ventures in another 1,712 rooms in two US hotels. Park was spun out of Hilton Worldwide Holdings at the start of 2017, so most of its hotels are still under the Hilton brand. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.